COVIDRIVE Partnership on COVID-19 vaccine effectiveness in Europe
COVIDRIVE is a not-for-profit public-private partnership launched in June 2021 to address the joint need to monitor COVID-19 vaccination programs
Menu
Our epidemiological studies
With a large team of epidemiologists, we have the capacity and experience to conduct and support epidemiological studies. Our activities range from primary data collection, non-interventional studies to different types of database studies.
- Non-interventional studies on: burden of disease, safety, effectiveness, healthcare resource utilization, and others
- Primary data collection
- Feasibility
- Protocol development
- Investigators identification
- Data capture, transfer and storage
- Data and site monitoring
- Analysis and reporting
- Secondary use of electronic health record (EHR) databases, and access to a wide range of databases on demand
- Feasibility and fit-for-purpose assessment
- Protocol development
- Analysis and reporting
VITAL: Vaccines and Infectious Diseases in the Ageing PopuLation
The VITAL project was launched in 2019, aiming to improve the efficacy of vaccines to protect the growing ageing population
CEPI ENABLE Study on the incidence of Lassa Fever in West Africa
The Enable Lassa Fever Research programme, funded by the Coalition for Epidemic Preparedness Innovations (CEPI), was launched in 2019 to
WHO Global Vaccine Safety Study in pregnancy
In 2017, the WHO launched the Global Vaccine Safety Multi-Country Collaboration Study on Safety in pregnancy to estimate the minimum
Other services
We offer a wide range of projects. Click on the icons below for more info.
Clinical research
End-to-end clinical trial services in different therapeutic areas
Systematic literature reviews
All stages from protocol to publication
Consultancy
Epidemiology, medical writing, statistics/IT and qualitative research
Pharmacovigilance
Analysis, regulatory documents and training